Issuer directory · Biotechnology · page 4
Biotechnology: issuers 301 to 400 of 832.
Ranked by the amount reported sold on the newest Form D. Page 1 holds the largest raises in the group.
| Issuer | Reported sold | Investors | Exemption | Newest notice | Filings | Platform |
|---|---|---|---|---|---|---|
| PHOTOPHARMICS INC | $26.2M | 47 | 506(b) | Nov 3, 2025 | 3 | direct |
| Ramona Optics, Inc. | $26.0M | 32 | 506(b) | Mar 12, 2026 | 1 | direct |
| iBio, Inc. | $26.0M | 7 | 506(b) | Jan 22, 2026 | 1 | direct |
| Opus Genetics, Inc. | $25.8M | 11 | 506(b) | Nov 7, 2024 | 1 | direct |
| Epicore Biosystems, Inc. | $25.7M | 4 | 506(b) | Apr 7, 2025 | 2 | direct |
| Laza Medical, Inc. | $25.5M | 45 | 506(b) | Dec 13, 2023 | 1 | direct |
| Elion Therapeutics, Inc. | $25.4M | 6 | 506(b) | Jun 26, 2024 | 1 | direct |
| eGenesis, Inc. | $25.4M | 11 | 506(b) | Feb 27, 2024 | 1 | direct |
| Microbot Medical Inc. | $25.2M | 1 | 506(b) | Sep 30, 2025 | 1 | direct |
| Forte Biosciences, Inc. | $25.0M | 27 | 506(b) | Aug 9, 2023 | 1 | direct |
| SPINEOLOGY INC | $25.0M | 33 | 506(b) | Aug 6, 2024 | 1 | direct |
| Blaze Bioscience, Inc. | $25.0M | 3 | 506(b) | Oct 21, 2024 | 1 | direct |
| AMPLIFICA HOLDINGS GROUP, INC. | $25.0M | 28 | 506(b) | Aug 20, 2026 | 1 | direct |
| Judo Bio Inc. | $25.0M | 21 | 506(b) | Aug 16, 2024 | 1 | direct |
| Lonestar Medicines, Inc. | $25.0M | 4 | 506(b) | Feb 23, 2026 | 1 | direct |
| Converge Bio Inc. | $25.0M | 19 | 506(b) | Apr 28, 2026 | 1 | direct |
| DELCATH SYSTEMS, INC. | $25.0M | 17 | 506(b) | Mar 31, 2023 | 1 | direct |
| C2N Diagnostics, LLC | $25.0M | 3 | 506(b) | Sep 26, 2024 | 2 | direct |
| SYNTIS BIO, INC. | $25.0M | 12 | 506(b) | Jul 2, 2025 | 1 | direct |
| Kayak Therapeutics, Inc. | $25.0M | 137 | 506(b) | Aug 21, 2026 | 2 | direct |
| Unnatural Products Inc. | $25.0M | 25 | 506(b) | Dec 22, 2023 | 2 | direct |
| Otolith Sound, Inc. | $24.8M | 33 | 506(b) | Feb 7, 2023 | 1 | direct |
| Cellectar Biosciences, Inc. | $24.5M | 21 | 506(b) | Sep 22, 2023 | 1 | direct |
| Faeth Therapeutics, Inc. | $24.4M | 35 | 506(b) | Jan 27, 2026 | 1 | direct |
| Myrobalan Therapeutics Holding, Inc. | $24.0M | 12 | 506(b) | Jan 24, 2024 | 1 | direct |
| Veralox Therapeutics Inc. | $24.0M | 14 | 506(b) | Jun 21, 2023 | 1 | direct |
| AOA DX Inc. | $23.6M | 119 | 506(b) | Jul 26, 2023 | 1 | direct |
| SunBird Bio, Inc. | $23.2M | 10 | 506(b) | May 12, 2023 | 1 | direct |
| Astrin Biosciences, Inc. | $22.9M | 21 | 506(b) | Jun 11, 2024 | 1 | direct |
| Trellis Bioscience, Inc. | $22.9M | 88 | 506(b) | Oct 21, 2026 | 1 | direct |
| VOLITIONRX LTD | $22.6M | 1 | 506(b) | Jan 28, 2026 | 2 | direct |
| Pacegenix, Inc. | $22.5M | 15 | 506(b) | Mar 26, 2026 | 1 | direct |
| MediSix Therapeutics, Inc. | $22.5M | 5 | 506(b) | Aug 4, 2023 | 2 | direct |
| X-Therma Inc. | $22.4M | 39 | 506(b) | Mar 8, 2024 | 1 | direct |
| Elucida Oncology, Inc. | $22.3M | 107 | 506(b) | Aug 3, 2023 | 2 | direct |
| March Biosciences, Inc. | $22.1M | 22 | 506(b) | Oct 22, 2024 | 1 | direct |
| TriSalus Life Sciences, Inc. | $22.0M | 24 | 506(b) | May 8, 2025 | 1 | direct |
| Angiex, Inc. | $22.0M | 137 | 506(c) | Sep 26, 2025 | 2 | direct |
| EnPlusOne Biosciences Inc. | $21.8M | 7 | 506(b) | Dec 26, 2024 | 3 | direct |
| Oncocyte Corp | $21.7M | 12 | 506(b) | Feb 24, 2025 | 1 | direct |
| NextCure, Inc. | $21.5M | 12 | 506(b) | Dec 10, 2025 | 1 | direct |
| Gemelli Biotech Corp. | $21.2M | 128 | 506(b) | Dec 2, 2024 | 2 | direct |
| DILON TECHNOLOGIES INC | $21.1M | 148 | 506(b) | Jan 14, 2025 | 2 | direct |
| Alloplex Biotherapeutics, Inc. | $20.7M | 51 | 506(b) | Feb 13, 2023 | 1 | direct |
| Access Vascular, Inc. | $20.6M | 19 | 506(b) | Oct 30, 2023 | 1 | direct |
| Beyond Air, Inc. | $20.6M | 15 | 506(b) | Oct 11, 2024 | 1 | direct |
| Immunis, Inc. | $20.4M | 27 | 506(b) | Oct 24, 2024 | 2 | direct |
| IconOVir Bio, Inc. | $20.2M | 34 | 506(b) | Jun 4, 2024 | 2 | direct |
| IN8BIO, INC. | $20.1M | 17 | 506(b) | Dec 30, 2025 | 1 | direct |
| Molecular Templates, Inc. | $20.0M | 19 | 506(b) | Jul 31, 2023 | 1 | direct |
| Santa Ana Bio, Inc. | $20.0M | 10 | 506(b) | Jun 17, 2024 | 1 | direct |
| XENTER, INC. | $19.6M | 79 | 506(b) | Jan 6, 2023 | 2 | direct |
| Rejuvenate Bio Inc | $19.5M | 35 | 506(b) | Jun 18, 2026 | 1 | direct |
| Mach5 Therapeutics, Inc. | $19.2M | 15 | 506(b) | Nov 4, 2024 | 1 | direct |
| Rapalogix Health, Inc. | $19.1M | 28 | 506(b) | Jun 26, 2026 | 1 | direct |
| Remedy Plan, Inc. | $19.1M | 22 | 506(b) | Aug 10, 2023 | 1 | direct |
| Nuclein, LLC | $19.1M | 49 | 506(b) | Apr 27, 2026 | 4 | direct |
| MaraBio Systems Inc. | $19.1M | 25 | 506(b) | Oct 7, 2024 | 1 | direct |
| CraniUS LLC | $19.0M | 49 | 506(b) | Mar 6, 2026 | 1 | direct |
| Vergent Bioscience, Inc. | $18.7M | 20 | 506(b) | Oct 20, 2025 | 1 | direct |
| SS Innovations International, Inc. | $18.6M | 25 | 506(b) | Mar 19, 2026 | 1 | direct |
| GENELUX Corp | $18.3M | 69 | 506(b) | Jun 15, 2023 | 1 | direct |
| Second Heart Assist, Inc. | $18.3M | 284 | 506(b) | Feb 7, 2025 | 1 | direct |
| AILERON THERAPEUTICS INC | $18.3M | 15 | 506(b) | Nov 16, 2023 | 1 | direct |
| Magnendo Corp. | $18.0M | 10 | 506(b) | Jul 29, 2026 | 1 | direct |
| ClearPoint Neuro, Inc. | $17.9M | 46 | 506(b) | Feb 5, 2026 | 1 | direct |
| LyGenesis Inc. | $17.8M | 17 | 506(b) | Oct 11, 2024 | 2 | direct |
| Potrero Medical, Inc. | $17.7M | 99 | 506(b) | Apr 10, 2023 | 1 | direct |
| Petal Surgical, Inc. | $17.7M | 40 | 506(b) | Aug 29, 2025 | 1 | direct |
| Affini-T Therapeutics, Inc. | $17.6M | 65 | 506(b) | Oct 15, 2024 | 1 | direct |
| CuraSen Therapeutics, Inc. | $17.6M | 11 | 506(b) | Oct 12, 2023 | 2 | direct |
| Pluton Biosciences, Inc. | $17.6M | 12 | 506(b) | Jun 2, 2023 | 1 | direct |
| CardioMech AS | $17.6M | 58 | 506(b) | Apr 21, 2025 | 1 | direct |
| Biolog, Inc. /DE/ | $17.5M | 20 | 506(b) | Feb 6, 2023 | 2 | direct |
| Amicrobe, Inc. | $16.7M | 32 | 506(b) | Apr 25, 2024 | 1 | direct |
| Pep2Tango Therapeutics, Inc. | $16.7M | 12 | 506(b) | Nov 21, 2024 | 1 | direct |
| Starget Pharma Inc. | $16.4M | 29 | 506(b) | Feb 3, 2026 | 1 | direct |
| Tempo Therapeutics, Inc. | $16.3M | 26 | 506(b) | Mar 15, 2024 | 1 | direct |
| BiomEdit, Inc. | $16.0M | 17 | 506(b) | Jun 26, 2025 | 1 | direct |
| OverT Bio, Inc. | $16.0M | 15 | 506(b) | May 9, 2024 | 2 | direct |
| Ambrosia Biosciences Inc. | $16.0M | 7 | 506(b) | Aug 20, 2024 | 2 | direct |
| Inceptor Bio, LLC | $15.9M | 13 | 506(b) | Jul 24, 2024 | 2 | direct |
| LUMINOPIA, INC. | $15.8M | 10 | 506(b) | Jun 29, 2023 | 1 | direct |
| Altay Therapeutics, Inc. | $15.7M | 19 | 506(b) | Oct 2, 2026 | 1 | direct |
| KKR FlowMod Aggregator LLC | $15.7M | 12 | 506(b) | Feb 27, 2025 | 1 | direct |
| Smart Health Diagnostics Co | $15.6M | 64 | 506(b) | May 13, 2024 | 3 | direct |
| Syndex Bio Inc. | $15.5M | 12 | 506(b) | Mar 14, 2025 | 1 | direct |
| Reprise Biomedical, Inc. | $15.3M | 64 | 506(b) | Jan 25, 2023 | 2 | direct |
| Tolerance Bio Inc. | $15.1M | 13 | 506(b) | Jun 18, 2026 | 1 | direct |
| Aminex Therapeutics, Inc. | $15.1M | 162 | 506(b) | Dec 5, 2025 | 1 | direct |
| InSitu Biologics, Inc. | $15.0M | 27 | 506(b) | Nov 10, 2026 | 2 | direct |
| Hoofprint Biome, Inc. | $15.0M | 13 | 506(b) | May 27, 2025 | 1 | direct |
| Nasus Pharma Ltd | $15.0M | 15 | 506(b) | Feb 25, 2026 | 1 | direct |
| Sonavex, Inc. | $15.0M | 45 | 506(b) | Nov 19, 2024 | 2 | direct |
| Gliknik Inc | $15.0M | 11 | 506(b) | Sep 17, 2026 | 2 | direct |
| Edesa Biotech, Inc. | $15.0M | 15 | 506(b) | Feb 14, 2025 | 1 | direct |
| SYNNOVATION THERAPEUTICS, INC. | $15.0M | 7 | 506(b) | Dec 21, 2023 | 2 | direct |
| Pictura Bio US, Inc. | $15.0M | 20 | 506(b) | Sep 28, 2026 | 1 | direct |
| Grace Therapeutics, Inc. | $15.0M | 14 | 506(b) | Feb 25, 2025 | 1 | direct |
| Epi Labs Inc. | $14.8M | 15 | 506(b) | Apr 30, 2026 | 1 | direct |
